Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Jewel PCD

This article was originally published in The Gray Sheet

Executive Summary

Firm launches two models of its Jewel PCD implantable defibrillators outside the U.S. The Model 7219D provides "full-feature tiered therapy," and the Model 7202D "offers basic defibrillation capabilities," Medtronic says. Because of their small size, the devices can be implanted near the shoulder rather than the abdominal area, which "significantly simplifies implantation," according to the firm. The devices have been undergoing clinical testing in Europe and Canada since March. U.S. clinical studies were initiated in September ("The Gray Sheet" Sept. 27, I&W-6)
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT001669

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel